53 Trending Stocks

Thu, Jan 21, 2021

Celgene

CELG 0.00
0.00 (0.0%)

9 x 0.00 = 0
x $0.00 =

NASDAQ: CELG Health Care Sector. Biotech & Pharma Industry. 5 Year Return 7%. 1 Year Return 11%. 2021 YTD Return 100%.

ST

External Links

Charts

image
image

52WL $5.18

The 52 Week Low is $5.18 set on Fri, Feb 28, 2020.

52WH $13.83

The 52 Week High is $13.83 set on Tue, Jun 2, 2020.

ATH $0.00

The All-Time High is $0.00 set on Wed, Dec 31, 1969.

52 Week Range

$5.18
$13.83
Feb 28, 2020
Jun 2, 2020

Earnings

2.38

Earnings Per Share

17.70

Price To Earnings Ratio


for

Wed, Dec 31, 1969

Since Report


for

Wed, Dec 31, 1969

Since Report

Dividends

0.00

Dividend Yield

0.00

Dividend Rate

--

Ex-Dividend Date

--

Dividend Payment Date

--

Dividend Frequency

0

Dividend History

Profile

Celgene trades on the NASDAQ. CELG's market cap is --.

Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma drug Istodax, and cancer drug Abraxane. The firm's first immunology drug, Otezla, was approved in the U.S. in 2014. Recent acquisitions of Juno and Impact bring additional drugs for Celgene's blood cancer pipeline.

Website

Related Channels

Free Channels & more...

For Starters

Account Channels

Track your portfolio and more.